Page 5 - Loncode Institute News Today

Investegate announcements from Active Biotech, Correction: Active Biotech Year End Report 2021

At its meeting on February 22, 2022, Sanofi’s Board of Directors has decided to propose, on the occasion of its next General Shareholder Meeting to be held on May 3, 2022, the renewal of the mandates of Paul Hudson, Christophe Babule, Patrick Kron and Gilles Schnepp and the appointment of Carole Ferrand, Emile Voest and Antoine Yver as independent Directors. Melanie Lee and Carole Piwnica will leave the Board of Directors.

Investegate announcements from Sanofi - Aventis Groupe, Sanofi’s Board of Directors proposes the appointment of Carole Ferrand, Emile Voest and Antoine Yver as independent Directors

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

/PRNewswire/ -- LSP announced today that it has raised over EUR 1 billion for its flagship fund LSP 7. This constitutes the final close of the largest life...

AMSTERDAM, Feb. 11, 2022 /PRNewswire/ -- LSP announced today that it has raised over EUR 1 billion for its flagship fund LSP 7. This constitutes the final close of the largest life sciences

/PRNewswire/ -- LSP announced today that it has raised over EUR 1 billion for its flagship fund LSP 7. This constitutes the final close of the largest life...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Lund, February 9, 2022 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced it has entered into an exclusive license agreement with Oncode Institute in the Netherlands, for the global rights to patents

Investegate announcements from Active Biotech, Active Biotech enters into global patent license agreement with Oncode Institute for tasquinimod in myelofibrosis